Methylation specific oligonucleotide microarray

From WikiMD's WELLNESSPEDIA

File:MSO microarray diagram.png
MSO microarray diagram


Methylation specific oligonucleotide microarray (MSO microarray) is a high-throughput technique used to analyze DNA methylation patterns across the genome. This method combines the principles of microarray technology with methylation-specific detection, allowing researchers to study epigenetic modifications on a large scale.

Overview[edit]

DNA methylation is a crucial epigenetic modification involving the addition of a methyl group to the cytosine or adenine nucleotides in DNA. This process plays a significant role in regulating gene expression, genomic imprinting, X-chromosome inactivation, and suppression of transposable elements. Abnormal DNA methylation patterns are associated with various diseases, including cancer, neurological disorders, and cardiovascular diseases.

Principle[edit]

The MSO microarray technique involves several key steps: 1. DNA Extraction: Genomic DNA is extracted from the sample of interest. 2. Bisulfite Treatment: The DNA is treated with sodium bisulfite, which converts unmethylated cytosines to uracil, while methylated cytosines remain unchanged. 3. PCR Amplification: The bisulfite-treated DNA is amplified using polymerase chain reaction (PCR) with primers specific to methylated or unmethylated sequences. 4. Hybridization: The amplified DNA is hybridized to an oligonucleotide microarray containing probes specific to methylated and unmethylated sequences. 5. Detection and Analysis: The hybridized microarray is scanned, and the data is analyzed to determine the methylation status of the target sequences.

Applications[edit]

MSO microarrays are used in various research and clinical applications, including:

  • Cancer Research: Identifying methylation biomarkers for early detection, prognosis, and therapeutic targets.
  • Epigenetic Studies: Investigating the role of DNA methylation in gene regulation and development.
  • Disease Diagnosis: Developing diagnostic tools for diseases associated with abnormal methylation patterns.
  • Pharmacogenomics: Studying the impact of DNA methylation on drug response and personalized medicine.

Advantages and Limitations[edit]

Advantages[edit]

  • High-throughput: Allows simultaneous analysis of thousands of CpG sites.
  • Sensitivity: Capable of detecting low levels of methylation.
  • Specificity: Differentiates between methylated and unmethylated sequences.

Limitations[edit]

  • Cost: Relatively expensive compared to other methylation analysis methods.
  • Complexity: Requires specialized equipment and expertise.
  • Limited Coverage: May not cover all CpG sites in the genome.

See Also[edit]

References[edit]

External Links[edit]